Hansoh Pharma, Hongqiao tap Asia CB market

Jonathan Breen

January 08, 2021 08:15 AM

dollar_adobe_575x375_20

Hong Kong-listed Hansoh Pharmaceutical Group and China Hongqiao Group have added to the burst of convertible bond activity in the first week of 2021, raising a combined $900m from the equity-linked market on Thursday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Health and Biotech UBS Equity China Merchants Bank Co China China International Capital Corp ING Hong Kong SAR Asia Greater China Northeast Asia Asia Pacific SRI Taiwan Citi Crédit Agricole Emerging Markets Equity-Linked

JB

Jonathan Breen

Equities editor GlobalCapital Asia